Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130558 · ClinicalTrials.gov registry record · NA
Efficacy of Structured Insulin Order
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT01130558: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01130558 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01130558, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an electronic order template for basal-bolus insulin will improve mean blood glucose in hospitalized general medical patients with poorly controlled type 2 diabetes.
Interventions
- OTHER Diabetes Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130558
The ClinicalTrials.gov registry entry for NCT01130558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Management is the first listed.
NCT01130558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01130558 about?
NCT01130558 is a clinical study titled "Efficacy of Structured Insulin Order". The purpose of this study is to determine whether an electronic order template for basal-bolus insulin will improve mean blood glucose in hospitalized general medical patients with poorly controlled type 2 diabetes.
What is the current status of trial NCT01130558?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2009-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01130558?
The interventions under investigation include: Diabetes Management (OTHER).
Who is sponsoring clinical trial NCT01130558?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.